Mallinckrodt Pharmaceuticals
Mallinckrodt, which has its headquarters in Mulhuddart, Dublin 15 but operates from its location in Missouri in the US, is a global specialty biopharmaceutical and medical imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. Mallinckrodt was spun-off by Covidien in 2013.
Financial Data
-
25th Dec 20 Source: CRO
- €1.8 billion turnover
-
-€814.7 million
profit - 3,289 employees
-
31st Dec 19 Source: CRO
- €3.2 billion turnover
-
-€1.4 billion
profit - 3,403 employees
- 4 more years available »
Ranking
By Turnover
(€1.8 billion)- 59th in Top Companies
By Employees
(3,289)- 76th in Top Companies
- 3,289
- €1.8 billion
Employees
- David Keenan Vice President}
Latest News
- 4:16pm BioNTech aims to develop first mRNA-based malaria vaccine
- 3:29pm ‘Total travesty’: 294 submissions made over plan to tackle challenges against planning proposals
- 2:57pm Aon’s $30bn acquisition of Willis Towers Watson collapses
- 2:47pm SSE to explore production of green hydrogen energy in Ireland
- 1:23pm Philips beats earnings forecast as it mobilises for respiratory device recall